The competitive landscape of the buffer industry is characterized by a high degree of concentration, with a few global giants holding a significant portion of the revenue. The Bio Pharma Buffer Market Share is currently dominated by major life sciences companies like Merck KGaA, Thermo Fisher Scientific, and Avantor. These companies benefit from their "end-to-end" portfolios, where they can...